Cargando…
Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis
OBJECTIVES: The aim was to define clinical characteristics and long-term survival of patients with dcSSc and positive ACA. METHODS: We identified all cases of ACA(+) SSc in our cohort (n = 1313). Those with dcSSc (ACA(+) diffuse) were compared with representative groups of consecutive ACA(+) patient...
Autores principales: | Caetano, Joana, Nihtyanova, Svetlana I, Harvey, Jennifer, Denton, Christopher P, Ong, Voon H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649979/ https://www.ncbi.nlm.nih.gov/pubmed/31431952 http://dx.doi.org/10.1093/rap/rky002 |
Ejemplares similares
-
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis
por: Spierings, Julia, et al.
Publicado: (2021) -
Pathogenesis of systemic sclerosis associated interstitial lung
disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020) -
Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
por: Clark, Kristina E. N., et al.
Publicado: (2022) -
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
por: Khanna, Dinesh, et al.
Publicado: (2020) -
Management of MDA-5 antibody-positive dermatomyositis with interstitial lung disease—an Auckland case series
por: Dick, Michael, et al.
Publicado: (2021)